Acceleration of diabetic wound healing by an angiopoietin peptide mimetic

Tissue Engineering - Part A

Volumn 15, Issue 6, 2009, Pages 1269-1280

  Van Slyke, Paul ^a,b   Alami, Jennifer ^a   Martin, Daniel ^b   Kuliszewski, Michael ^c   Leong Poi, Howard ^c   Sefton, Michael V ^d   Dumont, Dan ^a,b,e  

^a Sunnybrook Health Sciences Centre   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e Research Prevention and Cancer Control   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; BIOMIMETICS; BLOOD VESSEL PROSTHESES; ENZYME INHIBITION; EYE PROTECTION; GLUCOSE; SELF ASSEMBLY; SUGAR (SUCROSE);

ANGIOPOIETIN; ASSOCIATED SIGNALING; BIOLOGICAL RESPONSE; BLOOD GLUCOSE LEVEL; CLINICAL CONDITIONS; DIABETIC PATIENT; DIABETIC RETINOPATHY; MATRIX METALLOPROTEINASE-2; MICROVASCULAR; MYOGENIC CELLS; NEPHROPATHY; PEPTIDOMIMETIC; PERIPHERAL ARTERY DISEASE; PROOF OF PRINCIPLES; UNDERLYING CAUSE; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULATURE; WOUND CLOSURE; WOUND HEALING;

ENDOTHELIAL CELLS;

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; GELATINASE A; UNCLASSIFIED DRUG; VASCULOTIDE; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL STIMULATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; GRANULATION TISSUE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; WOUND CLOSURE; WOUND HEALING;

MUS;

EID: 66249112824     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2007.0400     Document Type: Article

References (43)

1. Kampfer, H., Pfeilschifter, J., and Frank, S. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest 81, 361, 2001.
2. Cho, C.H., Sung, H.K., Kim, K.T., Cheon, H.G., Oh, G.T., Hong, H.J., Yoo, O.J., and Koh, G.Y. COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model. Proc Natl Acad Sci USA 103, 4946, 2006.
3. Ward, N.L., and Dumont, D.J. The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development. Semin Cell Dev Biol 13, 19, 2002.
4. Tsigkos, S., Koutsilieris, M., and Papapetropoulos, A. Angiopoietins in angiogenesis and beyond. Expert Opin Investig Drugs 12, 933, 2003.
5. Procopio, W.N., Pelavin, P.I., Lee, W.M., and Yeilding, N.M. Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity. J Biol Chem 274, 30196, 1999.
6. Davis, S., Papadopoulos, N., Aldrich, T.H., Maisonpierre, P.C., Huang, T., Kovac, L., Xu, A., Leidich, R., Radziejewska, E., Rafique, A., Goldberg, J., Jain, V., Bailey, K., Karow, M., Fandl, J., Samuelsson, S.J., Ioffe, E., Rudge, J.S., Daly, T.J., Radziejewski, C., and Yancopoulos, G.D. Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat Struct Biol 10, 38, 2003.
7. Cho, C.H., Kammerer, R.A., Lee, H.J., Steinmetz, M.O., Ryu, Y.S., Lee, S.H., Yasunaga, K., Kim, K.T., Kim, I., Choi, H.H., Kim, W., Kim, S.H., Park, S.K., Lee, G.M., and Koh, G.Y. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci USA 101, 5547, 2004.
8. Ward, N.L., van Slyke, P., and Dumont, D.J. Functional inhibition of secreted angiopoietin: a novel role for angio-poietin 1 in coronary vessel patterning. Biochem Biophys Res Commun 323, 937, 2004.
9. Tournaire, R., Simon, M.P., le Noble, F., Eichmann, A., England, P., and Pouyssegur, J. A short synthetic peptide inhibits signal transduction, migration and angiogenesis mediated by Tie2 receptor. EMBO Rep 5, 262, 2004.
10. Bogdanovic, E., Nguyen, V.P., and Dumont, D.J. Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization. J Cell Sci 119(Pt 17), 3551, 2006.
11. Jones, N., and Dumont, D.J. The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R. Oncogene 17, 1097, 1998.
12. Jones, N., and Dumont, D.J. Recruitment of Dok-R to the EGF receptor through its PTB domain is required for attenuation of erk MAP kinase activation. Curr Biol 9, 1057, 1999.
13. Bernini, F., Bellosta, S., Corsini, A., Maggi, F.M., Fumagalli, R., and Catapano, A.L. Cholesterol stimulation of HDL binding to human endothelial cells EAhy 926 and skin fibroblasts: evidence for a mechanism independent of cellular metabolism. Biochim Biophys Acta 1083, 94, 1991.
14. Stringer, J.R. Mutant of simian virus 40 large T-antigen that is defective for viral DNA synthesis, but competent for transformation of cultured rat cells. J Virol 42, 854, 1982.
15. Wang, S.J., Greer, P., and Auerbach, R. Isolation and propagation of yolk-sac-derived endothelial cells from a hypervascular transgenic mouse expressing a gain-of-function fps/fes proto-oncogene. In Vitro Cell Dev Biol Anim 32, 292, 1996.
16. Master, Z., Jones, N., Tran, J., Jones, J., Kerbel, R.S., and Dumont, D.J. Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of Pak. EMBO J 20, 5919, 2001.
17. Voskas, D., Jones, N., van Slyke, P., Sturk, C., Chang, W., Haninec, A., Babichev, Y.O., Tran, J., Master, Z., Chen, S., Ward, N., Cruz, M., Jones, J., Kerbel, R.S., Jothy, S., Dagnino, L., Arbiser, J., Klement, G., and Dumont, D.J. A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice. Am J Pathol 166, 843, 2005.
18. Master, Z., Tran, J., Bishnoi, A., Chen, S.H., Ebos, J.M., van Slyke, P., Kerbel, R.S., and Dumont, D.J. Dok-R binds c-Abl and regulates Abl kinase activity and mediates cytoskeletal reorganization. J Biol Chem 278, 30170, 2003.
19. Kim, I., Kim, H.G., So, J.N., Kim, J.H., Kwak, H.J., and Koh, G.Y. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. Circ Res 86, 24, 2000.
20. Fujikawa, K., de Aos Scherpenseel, I., Jain, S.K., Presman, E., and Varticovski, L. Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells. Exp Cell Res 253, 663, 1999.
21. Babaei, S., Teichert-Kuliszewska, K., Zhang, Q., Jones, N., Dumont, D.J., and Stewart, D.J. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am J Pathol 162, 1927, 2003.
22. Brkovic, A., Pelletier, M., Girard, D., and Sirois, M.G. Angiopoietin chemotactic activities on neutrophils are regulated by PI-3K activation. J Leukoc Biol 81, 1093, 2007.
23. Sturn, D.H., Feistritzer, C., Mosheimer, B.A., Djanani, A., Bijuklic, K., Patsch, J.R., and Wiedermann, C.J. Angiopoietin affects neutrophil migration. Microcirculation 12, 393, 2005.
24. Murdoch, C., Tazzyman, S., Webster, S., and Lewis, C.E. Expression of tie-2 by human monocytes and their responses to angiopoietin-2. J Immunol 178, 7405, 2007.
25. van der Geer, P., Hunter, T., and Lindberg, R.A. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 10, 251, 1994.
26. Gruber, B.L., Marchese, M.J., and Kew, R. Angiogenic factors stimulate mast-cell migration. Blood 86, 2488, 1995.
27. Maliba, R., Brkovic, A., Neagoe, P.E., Villeneuve, L.R., and Sirois, M.G. Angiopoietin-mediated endothelial P-selectin translocation: cell signaling mechanisms. J Leukoc Biol. 83, 2008.
28. Hu, B., Jarzynka, M.J., Guo, P., Imanishi, Y., Schlaepfer, D.D., and Cheng, S.Y. Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. Cancer Res 66, 775, 2006.
29. Carlson, T.R., Feng, Y., Maisonpierre, P.C., Mrksich, M., and Morla, A.O. Direct cell adhesion to the angiopoietins mediated by integrins. J Biol Chem 276, 26516, 2001.
30. Kwak, H.J., So, J.N., Lee, S.J., Kim, I., and Koh, G.Y. Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett 448, 249, 1999.
31. Harfouche, R., and Hussain, S.N. Signaling and regulation of endothelial cell survival by angiopoietin-2. Am J Physiol Heart Circ Physiol 291, H1635, 2006.
32. Witzenbichler, B., Maisonpierre, P.C., Jones, P., Yancopoulos, G.D., and Isner, J.M. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 273, 18514, 1998.
33. Connolly, D.T., Heuvelman, D.M., Nelson, R., Olander, J.V., Eppley, B.L., Delfino, J.J., Siegel, N.R., Leimgruber, R.M., and Feder, J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84, 1470, 1989.
34. Suri, C., Jones, P.F., Patan, S., Bartunkova, S., Maisonpierre, P.C., Davis, S., Sato, T.N., and Yancopoulos, G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171, 1996.
35. Thurston, G., Rudge, J.S., Ioffe, E., Zhou, H., Ross, L., Croll, S.D., Glazer, N., Holash, J., McDonald, D.M., and Yancopoulos, G.D. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6, 460, 2000.
36. Mustoe, T.A., Cutler, N.R., Allman, R.M., Goode, P.S., Deuel, T.F., Prause, J.A., Bear, M., Serdar, C.M., and Pierce, G.F. A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers. Arch Surg 129, 213, 1994.
37. Sluiter, W., Pietersma, A., Lamers, J.M., and Koster, J.F. Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. J Cardiovasc Pharmacol 22 Suppl 4, S37, 1993.
38. Galiano, R.D., Tepper, O.M., Pelo, C.R., Bhatt, K.A., Callaghan, M., Bastidas, N., Bunting, S., Steinmetz, H.G., and Gurtner, G.C. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 164, 1935, 2004.
39. Peters, K.G., Kontos, C.D., Lin, P.C., Wong, A.L., Rao, P., Huang, L., Dewhirst, M.W., and Sankar, S. Functional significance of Tie2 signaling in the adult vasculature. Recent Prog Horm Res 59, 51, 2004.
40. Brindle, N.P., Saharinen, P., and Alitalo, K. Signaling and functions of angiopoietin-1 in vascular protection. Circ Res 98, 1014, 2006.
41. Li, L.Y., Barlow, K.D., and Metheny-Barlow, L.J. Angiopoietins and Tie2 in health and disease. Pediatr Endocrinol Rev 2, 399, 2005.
42. Daly, C., Pasnikowski, E., Burova, E., Wong, V., Aldrich, T.H., Griffiths, J., Ioffe, E., Daly, T.J., Fandl, J.P., Papadopoulos, N., McDonald, D.M., Thurston, G., Yancopoulos, G.D., and Rudge, J.S. Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci USA 103, 15491, 2006.
43. Lindahl, P., Hellstrom, M., Kalen, M., and Betsholtz, C. Endothelial-perivascular cell signaling in vascular development: lessons from knockout mice. Curr Opin Lipidol 9, 407, 1998.